| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4235967c3b70cd9dede0f0c1226dadda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66c1b22707b0276e3078713a6ddcba91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cdaa68c28a1d84317491748575c3e20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39fb1d35ebd917d11adda5aa4b51e337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16d015fa4c454e317beb863a9d50c272 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2004-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5db3fbe5dae447de82ed475acc253691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da2694f4949495560175ca3245a6b049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a393cffe1077d8cdf51cd4e48b3382e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b54ec6f9a53e99721c49d37c8aeb72e7 |
| publicationDate |
2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004099247-A2 |
| titleOfInvention |
Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| abstract |
Synthetic polynucleotides encoding human carcinoembryonic antigen (CEA) are provided, the synthetic polynucleotides being codon-optimized for expression in a human cellular environment. The gene encoding CEA is commonly associated with the development of human carcinomas. The present invention provides compositions and methods to elicit or enhance immunity to the protein product expressed by the CEA tumor-associated antigen, wherein aberrant CEA expression is associated with a carcinoma or its development. This invention specifically provides adenoviral vector and plasmid constructs carrying codon-optimed human CEA and discloses their use in vaccines and pharmaceutical compositions for preventing and treating cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005212479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8188244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007090596-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3864169-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-340715-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7862997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2567707-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005019455-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005077977-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1820865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10563224-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103360466-B |
| priorityDate |
2003-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |